Độ phát quang tự nhiên của da có thể giúp lựa chọn bệnh nhân tiểu đường loại 2 cho các quy trình sàng lọc tái thông mạch
Tóm tắt
Từ khóa
#độ phát quang tự nhiên của da #bệnh tiểu đường loại 2 #tái thông mạch #sàng lọc #bệnh tim mạchTài liệu tham khảo
Chen J, Arshi B, Waqas K, Lu T, Bos D, Ikram A, et al. Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study. Cardiovasc Diabetol. 2023;22(1):326. https://doi.org/10.1186/s12933-023-02052-7.
Yoshida M, Mita T, Yamamoto R, Shimizu T, Ikeda F, Ohmura C, et al. Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2012;35(1):178–80. https://doi.org/10.2337/dc11-1333.
Kim HL, Jeon WK, Joh HS, Lim WH, Seo JB, Kim SH, et al. Brachial-ankle pulse wave velocity as a predictor of long-term cardiovascular events in 2174 subjects with type 2 diabetes mellitus: a retrospective cohort study. Medicine (Baltimore). 2022;101(45): e31758. https://doi.org/10.1097/MD.0000000000031758.
Kramer CK, Zinman B, Gross JL, Canani LH, Rodrigues TC, Azevedo MJ, et al. Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis. BMJ. 2013;25(346): f1654. https://doi.org/10.1136/bmj.f1654.
Valensi P, Henry P, Boccara F, Cosson E, Prevost G, Emmerich J, et al. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: position paper of the French Society of Cardiology and the French-speaking Society of Diabetology. Arch Cardiovasc Dis. 2021;114(2):150–72. https://doi.org/10.1016/j.acvd.2020.07.003.
Mohammedi K, Préaubert N, Cariou T, Rigalleau V, Foussard N, Piazza L, et al. Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design. Cardiovasc Diabetol. 2021;20(1):63. https://doi.org/10.1186/s12933-021-01253-2.
Borderie G, Foussard N, Larroumet A, Blanco L, Barbet-Massin MA, Ducos C, et al. The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: a longitudinal observational study. J Diabetes Complications. 2023;37(10): 108595. https://doi.org/10.1016/j.jdiacomp.2023.108595.
Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, et al. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia. 2009;52(5):789–97. https://doi.org/10.1007/s00125-009-1308-9.
Jin Q, Lau ESH, Luk AOY, Ozaki R, Chow EYK, Cheng F, et al. Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: a prospective cohort study from the Hong Kong Diabetes Biobank. J Diabetes Complications. 2021;35(10): 108015. https://doi.org/10.1016/j.jdiacomp.2021.108015.
Boersma HE, van Waateringe RP, van der Klauw MM, Graaff R, Paterson AD, Smit AJ, et al. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes. BMC Endocr Disord. 2021;21(1):14. https://doi.org/10.1186/s12902-020-00676-4.
Hirai T, Fujiyoshi K, Yamada S, Matsumoto T, Kikuchi J, Ishida K, et al. Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease. Cardiovasc Diabetol. 2023;22(1):213. https://doi.org/10.1186/s12933-023-01953-x.
Pan J, Bao X, Gonçalves I, Jujić A, Engström G. Skin autofluorescence, a measure of tissue accumulation of advanced glycation end products, is associated with subclinical atherosclerosis in coronary and carotid arteries. Atherosclerosis. 2022;345:26–32. https://doi.org/10.1016/j.atherosclerosis.2022.02.014.